EAM Investors’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

EAM Investors’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-55,389	Closed	-$1.02M	–	358
2022 Q3	$1.02M	Buy	+55,389	New	+$869K	0.22%	209
2020 Q1	–	Sell	-58,404	Closed	-$3.63M	–	301
2019 Q4	$3.63M	Buy	+58,404	New	+$2.78M	0.8%	17
2018 Q4	–	Sell	-80,580	Closed	-$3.12M	–	333
2018 Q3	$3.12M	Sell	80,580 -4,446	-5%	-$164K	0.46%	105
2018 Q2	$3.35M	Buy	+85,026	New	+$2.5M	0.53%	62

Other funds holding DCPH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wolverine Trading Chicago, Illinois $139B AUM 31.83% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

EAM Investors's DCPH Position: Q4 2022 in Review

EAM Investors sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q4 2022, closing a stake of 55,389 shares — an estimated $1.02M sold.

EAM Investors first reported a position in DCPH in Q2 2018 and held it in 4 quarters. The position peaked at $3.63M in Q4 2019. 143 funds tracked by Wall St. Rank hold DCPH as of Q4 2022.

EAM Investors reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
EAM Investors sold 55,389 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q4 2022, an estimated $1.02M.
EAM Investors first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 4 quarters.
EAM Investors's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $3.63M in Q4 2019.
143 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q4 2022.

Based on EAM Investors's 13F filing for Q4 2022, filed 14 Feb 2023.